The association between serum interleukin-1 beta and heparin sulphate in diabetic nephropathy patients
-
Published:2021-12
Issue:6
Volume:38
Page:697-707
-
ISSN:0282-0080
-
Container-title:Glycoconjugate Journal
-
language:en
-
Short-container-title:Glycoconj J
Author:
Jiang LiqiongORCID, Zhou Jianying, Zhang Li, Du Yufeng, Jiang Mingming, Xie Liqian, Ma Zhenni, Chen Fengling
Abstract
AbstractInflammation is considered an important mechanism in the development of diabetes mellitus (DM) and persists for a long time before the occurrence of diabetic nephropathy (DN). Many studies have demonstrated that a decrease in the endothelial glycocalyx (EG) is negatively correlated with proteinuria. To elucidate whether EG damage induced by inflammasomes in DM patients leads to the occurrence of microalbuminuria (MA) and accelerates the progression of DN, this study screened 300 diagnosed DM patients. Finally, 70 type 2 diabetes patients were invited to participate in this study and were divided into two groups: the T2DM group (patients with normal MA and without diabetic retinopathy, n = 35) and the T2DN group (patients with increased MA and diabetic retinopathy, n = 35). Circulating heparin sulphate (HS, EG biomarkers) and interleukin-1 beta (IL-1β, inflammasome biomarkers) of the patients were measured by ELISA. Laboratory data were measured using routine laboratory methods. Patients in the T2DN group had increased serum HS, increased IL-1β, increased CRP, decreased haemoglobin, and increased neutrophils compared to patients in the T2DM group (all P < 0.05). Increased HS and decreased haemoglobin were independently associated with T2DN patients. ROC curves showed that the AUC of HS for the prediction of T2DN was 0.67 (P < 0.05). The combination of HS and haemoglobin yielded a significant increasement in the AUC (0.75, P < 0.001) with optimal sensitivity (71.2%) and specificity (79%). Furthermore, serum IL-1β was positively correlated with HS and was an independent associated factor of HS in the T2DN group. The relationship between HS and IL-1β was not significant in the T2DM group. Our findings surgessed the inflammasome may be associated with and promote damage to the EG during the disease course of DN that manifests as increased MA.
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology,Biochemistry
Reference42 articles.
1. Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A.A., Ogurtsova, K., Shaw, J.E., Bright, D., Williams, R.: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res. Clin. Pract. 157, 107843 (2019). https://doi.org/10.1016/j.diabres.2019.107843 2. Umanath, K., Lewis, J.B.: Update on Diabetic Nephropathy: Core Curriculum 2018. Am. J. Kidney Dis. 71(6), 884–895 (2018). https://doi.org/10.1053/j.ajkd.2017.10.026 3. Tuttle, K.R., Bakris, G.L., Bilous, R.W., Chiang, J.L., de Boer, I.H., Goldstein-Fuchs, J., Hirsch, I.B., Kalantar-Zadeh, K., Narva, A.S., Navaneethan, S.D., Neumiller, J.J., Patel, U.D., Ratner, R.E., Whaley-Connell, A.T., Molitch, M.E.: Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care 37(10), 2864–2883 (2014). https://doi.org/10.2337/dc14-1296 4. Boels, M.G., Avramut, M.C., Koudijs, A., Dane, M.J., Lee, D.H., van der Vlag, J., Koster, A.J., van Zonneveld, A.J., van Faassen, E., Gröne, H.J., van den Berg, B.M., Rabelink, T.J.: Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy. Diabetes 65(8), 2429–2439 (2016). https://doi.org/10.2337/db15-1413 5. Haraldsson, B., Nyström, J., Deen, W.M.: Properties of the glomerular barrier and mechanisms of proteinuria. Physiol. Rev. 88(2), 451–487 (2008). https://doi.org/10.1152/physrev.00055.2006
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|